Shareholders' equity · 2011–2025
Novavax shareholders' equity
−$128M+$496M · FY2025
Novavax (NVAX) reported −$128M in shareholders' equity for fiscal 2025, +$496M from the year before.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | −$128M | +$496M | Open → |
| FY20242024-12-31 | −$624M | +$93.1M | Open → |
| FY20232023-12-31 | −$717M | −$82.8M | Open → |
| FY20222022-12-31 | −$634M | −$282M | Open → |
| FY20212021-12-31 | −$352M | −$979M | Open → |
| FY20202020-12-31 | $627M | +$813M | Open → |
| FY20192019-12-31 | −$186M | −$18.1M | Open → |
| FY20182018-12-31 | −$168M | −$66.2M | Open → |
| FY20172017-12-31 | −$102M | −$96.2M | Open → |
| FY20162016-12-31 | −$5.5M | −$298M | Open → |
| FY20152015-12-31 | $293M | +27.5% | Open → |
| FY20142014-12-31 | $230M | +13.0% | Open → |
| FY20132013-12-31 | $203M | +153.3% | Open → |
| FY20122012-12-31 | $80.2M | +49.0% | Open → |
| FY20112011-12-31 | $53.8M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Novavax shareholders' equity |url=https://companiesranked.com/en/company/novavax/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Novavax shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/novavax/shareholders-equityBibTeX
@misc{companiesranked-en-company-novavax-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Novavax shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/novavax/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001000694-26-000018 · August 6, 2026
{{cite web |title=Novavax shareholders' equity — 10-Q (0001000694-26-000018) |url=https://www.sec.gov/Archives/edgar/data/1000694/000100069426000018/nvax-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.